Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily Clarke

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Clinics in Dermatology|September 26, 2025
Clinics in Dermatology: Herpes simplex virus (update on dermatologic aspects of sexually transmitted disease and human immunodeficiency virus)Emily Clarke
The Journal of Obstetrics and Gynaecology Research|November 6, 2025
Disseminated Herpes Simplex Virus in Pregnancy: A Systematic Review of CasesBethany Harrison, Emily Clarke
Frontline Gastroenterology|August 26, 2017
Low incidence of complications with Freka PEG tubesEmily Clarke, Stephen Lewis
International Journal of STD & AIDS|January 24, 2026
Topical aciclovir should not be used in the management of anogenital herpes simplex virusBronwyn Docherty Stewart, Emily Clarke
Immunology and Allergy Clinics of North America|April 4, 2024
Associations of Eosinophilic Gastrointestinal Disorders with Other Gastrointestinal and Allergic DiseasesSalvatore Oliva, Emily Clarke McGowan
Sexually Transmitted Infections|August 3, 2019
UK Sexual health clinics may be missing atypical syphilisBethany Harrison, Rajul Patel, Emily Clarke, et al.
International Journal of STD & AIDS|May 8, 2026
An evaluation of the clinical impact of serological testing for herpes simplex virus in a regional UK sexual health serviceCatriona Boyd, Martyn Wood, Emily Clarke
BMJ (Clinical Research Ed.)|July 16, 2014
Sex post GoldingEmily Clarke, J Green, R Patel
International Journal of STD & AIDS|March 17, 2026
Fracture risk assessment in patients prescribed pre-exposure prophylaxis for HIV: An audit and comparative evaluation of screening toolsQuin Healey, Martyn Wood, Emily Clarke
Acta Oncologica (Stockholm, Sweden)|August 19, 2021
The effects of PD-1/PD-L1 checkpoint inhibitors on recurrent/metastatic head and neck squamous cell carcinoma: a critical review of the literature and meta-analysisEmily Clarke, Jesper Grau Eriksen, Sarah Barrett
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Clinics in Dermatology|September 26, 2025
Clinics in Dermatology: Herpes simplex virus (update on dermatologic aspects of sexually transmitted disease and human immunodeficiency virus)Emily Clarke
The Journal of Obstetrics and Gynaecology Research|November 6, 2025
Disseminated Herpes Simplex Virus in Pregnancy: A Systematic Review of CasesBethany Harrison, Emily Clarke
Frontline Gastroenterology|August 26, 2017
Low incidence of complications with Freka PEG tubesEmily Clarke, Stephen Lewis
International Journal of STD & AIDS|January 24, 2026
Topical aciclovir should not be used in the management of anogenital herpes simplex virusBronwyn Docherty Stewart, Emily Clarke
Immunology and Allergy Clinics of North America|April 4, 2024
Associations of Eosinophilic Gastrointestinal Disorders with Other Gastrointestinal and Allergic DiseasesSalvatore Oliva, Emily Clarke McGowan
Sexually Transmitted Infections|August 3, 2019
UK Sexual health clinics may be missing atypical syphilisBethany Harrison, Rajul Patel, Emily Clarke, et al.
International Journal of STD & AIDS|May 8, 2026
An evaluation of the clinical impact of serological testing for herpes simplex virus in a regional UK sexual health serviceCatriona Boyd, Martyn Wood, Emily Clarke
BMJ (Clinical Research Ed.)|July 16, 2014
Sex post GoldingEmily Clarke, J Green, R Patel
International Journal of STD & AIDS|March 17, 2026
Fracture risk assessment in patients prescribed pre-exposure prophylaxis for HIV: An audit and comparative evaluation of screening toolsQuin Healey, Martyn Wood, Emily Clarke
Acta Oncologica (Stockholm, Sweden)|August 19, 2021
The effects of PD-1/PD-L1 checkpoint inhibitors on recurrent/metastatic head and neck squamous cell carcinoma: a critical review of the literature and meta-analysisEmily Clarke, Jesper Grau Eriksen, Sarah Barrett
Pageof 9